Impact of sarcopenia on short- and long-term outcomes after resection of perihilar cholangiocarcinoma: a two-center study
4 affiliations
- 1Department of Emergency Surgery, The First Affiliated Hospital of Henan University of Science and Technology
- 2Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Henan University of Science and Technology
- 3Department of Hepatobiliary and Pancreatic Surgery, People’s Hospital of Henan University
- 4Department of Gastroenterology, Zhengzhou University People’s Hospital
Abstract
Background Sarcopenia is associated with poor postoperative outcomes in patients with malignant tumors; however, its impact on perihilar cholangiocarcinoma (pCCA) patients remains unclear. This study aimed to evaluate the predictive value of sarcopenia for postoperative outcomes in patients undergoing resection for pCCA. Methods A total of 271 patients with perihilar cholangiocarcinoma (pCCA) who underwent surgical intervention between 2016 and 2021 were retrospectively recruited from two institutions. The patients were divided into training and validation cohorts at a 7:3 ratio. Sarcopenia was defined via cutoff values for the skeletal muscle index (SMI) of 52.2 cm²/m² for males and 39.2 cm²/m² for females, which were determined through optimal stratification. Logistic regression and Cox proportional hazards regression were employed to identify significant risk factors associated with postoperative outcomes. Additionally, a novel nomogram based on sarcopenia was developed and subsequently validated via receiver operating characteristic (ROC) curves, calibration curves, and clinical decision curve analysis (DCA). Results Of the 271 patients studied, 144 (53.1%) were diagnosed with sarcopenia. Patients with sarcopenia presented significantly higher rates of total complications, major complications, and 90-day readmissions, as well as poorer overall survival (OS), than did those without sarcopenia. multivariable Cox regression analysis revealed several independent risk factors for OS, including body mass index (BMI) (p = 0.026), high performance status (PS) score (p < 0.001), R1 surgical margin (p < 0.001), T stage IV (p < 0.001), COUNT score ≥ 5 (p = 0.005), and the presence of sarcopenia (p < 0.001). A novel nomogram incorporating these six factors was developed to predict OS at 12, 24, and 36 months. The model exhibited robust predictive performance, with a mean area under the curve (AUC) greater than 0.8. The calibration curve closely matched the ideal curve, and decision curve analysis (DCA) further validated the strong predictive ability and substantial positive net benefit of the nomogram. Conclusion Sarcopenia is a significant adverse factor for both postoperative complications and long-term survival in patients with pCCA following surgical resection.
Related
- Preoperative Risk Classification for Early Recurrence After Curative-Intent Resection of Perihilar Cholangiocarcinoma: A Single-Center Retrospective Study
- Preoperative sustained C-reactive protein elevation shortens patient survival after liver resection for perihilar cholangiocarcinoma : A retrospective cohort study with propensity score analyses
- Long-Term Outcomes of a Multidisciplinary Treatment Strategy Using Neoadjuvant Gemcitabine Plus S-1 Based on Anatomical Resectability Classification and Lymph Node Status in Patients with Perihilar Cholangiocarcinoma
- Safety of adjuvant brachytherapy combined with external beam radiotherapy for proximal bile duct pR1 in perihilar cholangiocarcinoma: a prospective registration study.
- A prognostic model combining hilar lymph node metastasis and preoperative anemia to predict outcomes after curative resection of intrahepatic cholangiocarcinoma.
BibTeX
@article{wei2026impact,
title = {{Impact of sarcopenia on short- and long-term outcomes after resection of perihilar cholangiocarcinoma: a two-center study}},
author = {Xingbo Wei and Haiyang Hu and Shipeng Li and Qiuzhong Li and Yifan Zhi and Jizhen Li and Hengli Zhu and Changqian Tang and Yongnian Ren and Yuqi Guo and Dongxiao Li and Deyu Li},
journal = {BMC Cancer},
year = {2026},
month = jul,
doi = {10.1186/s12885-026-16305-7},
url = {https://doi.org/10.1186/s12885-026-16305-7},
note = {CC BY},
}
RIS
TY - JOUR
TI - Impact of sarcopenia on short- and long-term outcomes after resection of perihilar cholangiocarcinoma: a two-center study
AU - Xingbo Wei
AU - Haiyang Hu
AU - Shipeng Li
AU - Qiuzhong Li
AU - Yifan Zhi
AU - Jizhen Li
AU - Hengli Zhu
AU - Changqian Tang
AU - Yongnian Ren
AU - Yuqi Guo
AU - Dongxiao Li
AU - Deyu Li
PY - 2026
DA - 2026/07/01
JO - BMC Cancer
DO - 10.1186/s12885-026-16305-7
UR - https://doi.org/10.1186/s12885-026-16305-7
AB - Background Sarcopenia is associated with poor postoperative outcomes in patients with malignant tumors; however, its impact on perihilar cholangiocarcinoma (pCCA) patients remains unclear. This study aimed to evaluate the predictive value of sarcopenia for postoperative outcomes in patients undergoing resection for pCCA. Methods A total of 271 patients with perihilar cholangiocarcinoma (pCCA) who underwent surgical intervention between 2016 and 2021 were retrospectively recruited from two institutions. The patients were divided into training and validation cohorts at a 7:3 ratio. Sarcopenia was defined via cutoff values for the skeletal muscle index (SMI) of 52.2 cm²/m² for males and 39.2 cm²/m² for females, which were determined through optimal stratification. Logistic regression and Cox proportional hazards regression were employed to identify significant risk factors associated with postoperative outcomes. Additionally, a novel nomogram based on sarcopenia was developed and subsequently validated via receiver operating characteristic (ROC) curves, calibration curves, and clinical decision curve analysis (DCA). Results Of the 271 patients studied, 144 (53.1%) were diagnosed with sarcopenia. Patients with sarcopenia presented significantly higher rates of total complications, major complications, and 90-day readmissions, as well as poorer overall survival (OS), than did those without sarcopenia. multivariable Cox regression analysis revealed several independent risk factors for OS, including body mass index (BMI) (p = 0.026), high performance status (PS) score (p < 0.001), R1 surgical margin (p < 0.001), T stage IV (p < 0.001), COUNT score ≥ 5 (p = 0.005), and the presence of sarcopenia (p < 0.001). A novel nomogram incorporating these six factors was developed to predict OS at 12, 24, and 36 months. The model exhibited robust predictive performance, with a mean area under the curve (AUC) greater than 0.8. The calibration curve closely matched the ideal curve, and decision curve analysis (DCA) further validated the strong predictive ability and substantial positive net benefit of the nomogram. Conclusion Sarcopenia is a significant adverse factor for both postoperative complications and long-term survival in patients with pCCA following surgical resection.
SN - 1471-2407
ER -